<?xml version="1.0" encoding="UTF-8"?>
<title-group>
 <article-title>First case of Dolutegravir and Darunavir/r multi drug-resistant HIV-1 in Cameroon following exposure to Raltegravir: lessons and implications in the era of transition to Dolutegravir-based regimens</article-title>
</title-group>
